MET-PF — MetLife, Inc.

MetLife Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Earnings: Reported at $1.6 billion or $2.37 per share, a 22% increase year-over-year. Excluding notable items, adjusted earnings were $1.6 billion or $2.34 per share, up 21%.
• Variable Investment Income: Reached $483 million, exceeding the quarterly outlook of $425 million, driven by a 3% return on private equity.
• Return on Equity: Adjusted ROE (excluding notables) was 16.7%, aligning with the target range of 15% to 17%.
• Direct Expense Ratio: Improved to 11.6%, ahead of the New Frontier strategy target of 12.1%.
• Shareholder Returns: Approximately $875 million returned through dividends and share repurchases in Q3, with $2.6 billion in buybacks year-to-date.

2. Strategic Updates and Business Highlights

• New Frontier Strategy: Continued execution of the strategy is driving growth, particularly in Group Benefits and Retirement Solutions.
• Group Benefits: Adjusted earnings of $457 million, up 6%, attributed to improved underwriting results and seasonal dental profitability.
• Retirement and Income Solutions: Adjusted earnings of $423 million, up 15%, with strong growth in structured settlements and longevity reinsurance.
• Asia Performance: Adjusted earnings of $473 million, a 36% increase, with sales up 34% driven by new product launches in Japan and strong performance in Korea and China.
• Latin America: Adjusted earnings of $222 million, up 2%, with continued business momentum and partnerships, including with MercadoLibre.
• Chariot Re Launch: A strategic partnership aimed at enhancing retirement liability origination capacity, with an initial transaction of approximately $10 billion.

3. Forward Guidance and Outlook

• Pension Risk Transfer (PRT): Anticipated to have a record fourth quarter with $12 billion in new mandates already secured.
• Expense Management: Expected to remain below the 12.1% target for the full year, aided by technology investments and operational efficiencies.
• Long-term Growth: Positive outlook for PRT business, with 94% of pension plan sponsors planning to derisk portfolios in the next five years.

4. Bad News, Challenges, or Points of Concern

• Mexico Tax Law Change: A notable charge of $71 million related to VAT deductions on health insurance claims, expected to reduce adjusted earnings by $50 million to $60 million in 2026.
• Group Benefits Underwriting: The group life mortality ratio was below the target range, raising concerns about future underwriting performance.
• Competitive Pressures: The market remains competitive, though rationally priced, which may impact growth rates in Group Benefits.

5. Notable Q&A Insights

• Asia Sales Momentum: Strong growth attributed to new product launches and enhancements, with expectations to exceed full-year sales guidance for 2025.
• PRT Competitive Landscape: The success in securing large PRT deals is linked to MetLife's financial strength and disciplined risk management.
• Expense Seasonality: Anticipated higher expenses in Q4, but overall expectations remain below the annual target due to proactive cost management and technology integration.
• Private Credit Concerns: MetLife maintains a disciplined approach to credit investments, focusing on high-quality assets and internal underwriting rather than relying on external ratings.

Overall, MetLife's Q3 2025 results reflect strong operational performance and strategic execution, although challenges such as regulatory changes and competitive pressures warrant close monitoring.